Literature DB >> 15854796

Microdialysis--theoretical background and recent implementation in applied life-sciences.

Nele Plock1, Charlotte Kloft.   

Abstract

In the past decade microdialysis has become a method of choice in the study of unbound tissue concentrations of both endogenous and exogenous substances. Microdialysis has been shown to offer information about substances directly at the site of action while being well tolerable and safe. The large variety of its field of application has been demonstrated. However, a few challenges have to be met to make this method generally applicable in routine applications. This review will provide an overview over theoretical aspects that have to be considered during the implementation of microdialysis. Moreover, a comparison between microdialysis and other tissue sampling techniques will demonstrate advantages and limitations of the methods mentioned. Subsequently, it will present a critical synopsis of a variety of scientific/biomedical applications of this method with emphasis on the most recent literature, focussing on target tissues while giving examples of substances examined. It is concluded that microdialysis will be of great value in future investigations of pharmacokinetics, pharmacodynamics and in monitoring of disease status and progression.

Mesh:

Year:  2005        PMID: 15854796     DOI: 10.1016/j.ejps.2005.01.017

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  52 in total

Review 1.  Bioequivalence for topical products--an update.

Authors:  Yogeeta Narkar
Journal:  Pharm Res       Date:  2010-09-22       Impact factor: 4.200

Review 2.  [Pharmacokinetics and pharmacodynamics of antibiotic therapy].

Authors:  S Beck; S G Wicha; C Kloft; M G Kees
Journal:  Anaesthesist       Date:  2014-10       Impact factor: 1.041

3.  Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis.

Authors:  Cornelia Buerger; Nele Plock; Pejman Dehghanyar; Christian Joukhadar; Charlotte Kloft
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

Review 4.  Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution.

Authors:  Martin Brunner; Oliver Langer
Journal:  AAPS J       Date:  2006-04-14       Impact factor: 4.009

5.  Assessment of topical bioequivalence using dermal microdialysis and tape stripping methods.

Authors:  Tuba Incecayir; Ilbeyi Agabeyoglu; Ulver Derici; Sukru Sindel
Journal:  Pharm Res       Date:  2011-04-16       Impact factor: 4.200

6.  Population pharmacokinetic modeling of the unbound levofloxacin concentrations in rat plasma and prostate tissue measured by microdialysis.

Authors:  Felipe K Hurtado; Benjamin Weber; Hartmut Derendorf; Guenther Hochhaus; Teresa Dalla Costa
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

7.  Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill Patients.

Authors:  Iris K Minichmayr; André Schaeftlein; Joseph L Kuti; Markus Zeitlinger; Charlotte Kloft
Journal:  Clin Pharmacokinet       Date:  2017-06       Impact factor: 6.447

8.  Correlation of 3-mercaptopropionic acid induced seizures and changes in striatal neurotransmitters monitored by microdialysis.

Authors:  Eric W Crick; Ivan Osorio; Mark Frei; Andrew P Mayer; Craig E Lunte
Journal:  Eur J Pharm Sci       Date:  2014-01-22       Impact factor: 4.384

9.  Pilot investigation on long-term subcutaneous microdialysis: proof of principle in humans.

Authors:  Franziska Simmel; Claudia Kirbs; Zeynep Erdogan; Edith Lackner; Markus Zeitlinger; Charlotte Kloft
Journal:  AAPS J       Date:  2012-10-13       Impact factor: 4.009

10.  Local hippocampal methamphetamine-induced reinforcement.

Authors:  Ulises M Ricoy; Joe L Martinez
Journal:  Front Behav Neurosci       Date:  2009-11-16       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.